NEW YORK (GenomeWeb News) – The National Institute of Mental Health will provide around $6 million and up to $24 million over four years to support researchers seeking biomarkers that could be used in predicting patient response to depression drugs.

The Biosignature Discovery for Personalized Treatment in Depression grant program will fund one or more projects that aim to identify a personalized treatment algorithm which will be tested in a future clinical trial, and will support a sample resource from depression patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.